Evidence mapPaperPMID 41580420Full record

ArticleNature communications2026

Modulation of Nudt21 levels reveals dose-dependent roles of alternative polyadenylation in tissue regeneration.

Nikolaos Tsopoulidis, Masaki Yagi, Justin Brumbaugh, Shinya Ito, Víctor López-Soriano, Robert Morris, Yoseop Yoon, Kathleen A Messemer, Kuan-Hung Lin, Eric F Zaniewski and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Nikolaos TsopoulidisDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Masaki YagiDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Justin BrumbaughDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-9605-2010
Shinya ItoCenter for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Heidelberg, Germany.
Víctor López-SorianoInternal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0009-0003-4621-7547
Robert MorrisMassachusetts General Hospital Cancer Center, Boston, MA, USA.
Yoseop YoonDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California Irvine, Irvine, CA, USA.
Kathleen A MessemerHarvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Kuan-Hung LinHarvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Eric F ZaniewskiMassachusetts General Hospital Cancer Center, Boston, MA, USA.ORCID 0009-0007-9309-5481
Rebecca GorelovDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Aaron J HuebnerDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.
Amy J WagersHarvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Hanno HockMassachusetts General Hospital Cancer Center and Center for Regenerative Medicine, Boston, MA, USA.ORCID 0000-0002-5201-9403
Günter KramerCenter for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Heidelberg, Germany.ORCID 0000-0001-7552-8393
Bernd BukauCenter for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Heidelberg, Germany.ORCID 0000-0003-0521-7199
Michael S HoetkerInternal Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.ORCID 0000-0001-8784-8263
Yongsheng ShiDepartment of Microbiology and Molecular Genetics, School of Medicine, University of California Irvine, Irvine, CA, USA.ORCID 0000-0003-2967-1230
Wilhelm HaasMassachusetts General Hospital Cancer Center, Boston, MA, USA.
Konrad HochedlingerDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA. khochedlinger@mgh.harvard.edu.ORCID 0000-0001-5811-5386

Funding

Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotencyR01HD103612 · MASSACHUSETTS GENERAL HOSPITAL · 2025 to 2025
$512k
Deutsche Forschungsgemeinschaft (German Research Foundation) 808940European UnionNICHD NIH HHS R01 HD103612
6 · The paper itself

Abstract

Stem cells continually self-renew and differentiate to sustain tissue homeostasis, yet the role of post-transcriptional mechanisms in guiding these processes remains incompletely understood. Here, we demonstrate that the regulation of 3'UTR length via alternative mRNA polyadenylation (APA) is essential for stem cell function across diverse tissues. Modulating the APA regulator Nudt21 reveals that stem cell self-renewal and differentiation depend on distinct dosage thresholds and thus can be uncoupled. Specifically, moderate Nudt21 suppression  elicits a maturation arrest of stem cells due to 3'UTR-shortening of differentiation-associated mRNAs that escape miRNA regulation and perturb ceRNA networks. By contrast, complete Nudt21 suppression additionally shortens the 3'UTRs of mRNAs encoding essential multiprotein complexes, including the nuclear pore, leading to complex destabilization, proteotoxic stress, DNA damage, and cell cycle arrest. Critically, deletion of the alternative 3'UTRs of individual nucleoporins recapitulates defects observed with Nudt21 loss. We further demonstrate that the co-translational assembly of dozens of protein complexes is impaired in Nudt21-deficient cells, providing a mechanistic framework for compromised complex integrity. Collectively, our results show that APA plays distinct, dose-dependent roles in stem cell homeostasis by fine-tuning the expression of differentiation-associated genes and coordinating the biogenesis of multiprotein complexes essential for cell cycle progression.

Indexed as

Cleavage And Polyadenylation Specificity FactorPolyadenylationRegenerationStem Cells3' Untranslated RegionsAnimalsCell DifferentiationCell Self RenewalDNA DamageHumansMicroRNAsNuclear Pore Complex ProteinsRNA, Messenger3' Untranslated RegionsCleavage And Polyadenylation Specificity FactorMicroRNAsNuclear Pore Complex ProteinsNudt21 protein, humanRNA, Messenger

Identifiers

PMID41580420
PMCPMC12936197

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.